VitaDAO – Pfizer Ventures raise millions for research on extending human life

• VitaDAO has raised $4.1 million from Pfizer Ventures among other investors.
• The latest fundraiser will fund its first biotech startup longevity research and development project.

VitaDAO has raised $4.1 million from Pfizer Ventures among other investors. The decentralized autonomous organization (DAO) focuses on raising funds for human life extension research.

Pharmaceutical giant Pfizer Ventures, venture fund Shine Capital, investment group L1 Digital, decentralized science organization BeakerDAO and Spaceship DAO are the main investors in the latest round of funding for VitaDAO.

Tyler Golato of the decentralized biotech protocol Molecule founded VitaDAO in 2021 to fund longevity research. Additionally, the organization mentions that it has a community of over 9,000 enthusiasts, researchers, and contributors. It is spending more than $3.5 million on the project by 2022, researching diseases of aging, repairing age-related damage to the body, and cellular biology.

The original VITA governs the VitaDAO organization token. In addition, holders can choose which projects to support, with a group of administrators, helping implement these proposals. The Group intends to expand beyond physical locations and is considering “a potential future sovereign network.”

Pfizer is, according to VitaDAO, the first pharmaceutical company to vote on the DAO proposal and participate in the incubation and commercialization of the VitaDAO project.

The newest funds to be used for the Longevity Research Project

The latest fundraiser will fund VitaDAO’s first biotech startup longevity research and development project. This will be announced in the first quarter of 2023. Furthermore, the company intends to invest more in the commercialization and licensing of non-fungible token (NFT) intellectual property (IP) through its partnership with Molecule.

On trend

How to Use KuCoin Exchange To Buy Bitcoin and Crypto [2022]

Several VitaDAO-funded projects have advanced to the next stage of development. This will include clinical trials with Mantis Photonics to diagnose Alzheimer’s disease using retinal imaging.

In addition, crypto enthusiasts have long been interested in the science of longevity and the prevention of human aging. In December 2021, Coinbase CEO Brian Armstrong founded NewLimit, a company to cure aging. Additionally, former Ripple CTO and current Stellar co-founder Jed McCaleb founded the Astera Institute to fund longevity research.

This article originally appeared here.

Here’s How To Stay Up To Date About Crypto With CryptosRUs!

Learn about Bitcoin, Ethereum and more at CryptosRus Academy.

For the best exchanges, check out our top exchange guide.

Secure your crypto with Ledger and Trade your way to victory with help from LuxAlgo

Sign up for our bi-weekly newsletter for exclusive news and analysis.

Follow CRU News Desk on Twitter for our latest articles and exclusive Twitter threads.

Keep up to date with George on Tik Tok, Instagram and his new clip channel.